This study investigates the hemodynamic responses of the cardiovascular system when a rotary blood pump is operating in the descending aorta, with a focus on the cerebral, coronary and renal autoregulation, using our in-house cardiovascular emulator. Several improvements have been made from our previous studies.
lower limits of the autoregulated region [24] .
31
The aim of this study is to investigate the hemodynamic responses of the cardiovascular system when a 32 rotary pump is operating in the descending aorta with a focus on the cerebral, coronary and renal circulation.
33
Since the regional autoregulation can be impaired in heart failure patients, the hemodynamic response is 34 investigated with intact and impaired regional autoregulation. An expected outcome is to estimate what 35 level of support is feasible while avoiding the previously mentioned risk of drops in perfusion to the coronary 36 and cerebral circulations.
37
The objectives of this study are met using our in-house multi-chamber Simulator of Cardio-Vascular
38
Loops (SCVL). Cardiovascular simulators offer a more controlled and inexpensive platform to evaluate the 39 performance of existing blood-contacting devices as well as new medical concepts, prior to in-vivo studies.
40
In recent years, much progress has been made in the design and development of cardiovascular simulators 41 with close similarity to a native system for research and training [25] [26] [27] [28] .
42
In the present study, several improvements have been made from our previous studies [6, 12, 13, 29] . The 43 coronary perfusion mechanism which causes the heart to be perfused only during diastole was implemented 44 using a solenoid valve. In addition, the coronary and renal autoregulation circulations, similar to the cerebral 45 autoregulation mechanism presented in our previous study [29] , were integrated into the SCVL system, with 46 autoregulation limits determined from the clinical data. 
Methodology

48
The native cardiovascular system of an adult human was emulated using our in-house SCVL system, as
49
shown in the schematic digram of Figure 1 .
50
Four elastic rubber chambers were used to model the native heart chambers. The left and right ventricles 51 (LV and RV) had a volume of 100 mL and the left and right atrium (LA and RA) had a volume of 50 mL.
52
Four linear motors (P01-37×120 from LinMot, Spreitenbach, Switzerland) were employed to simulate the 53 contraction and dilation of the ventricle and atrium chambers. Two trajectory time-varying functions 54 extracted from the real time left ventricle and left atrium volume, as described in our previous study [29] ,
55
were employed to actuate the four linear motors. Figure 2 shows the simultaneous graphs of trajectory 56 time-varying functions of the ventricles and atria for an intact heart. Each function can be scaled up or 57 down in order to replicate various physiological and pathological conditions.
58
Four prosthetic heart valves (Medtronic, Minneapolis, Minnesota, USA) modelling the aortic ,mitral,
59
pulmonary and tricuspid valves were used to ensure unidirectional flow in the vicinity of each chamber. The systemic and pulmonary circulations are replicated using 24 mm diameter rubber tubing, while smaller circulations was replicated using a number of compliance units developed in our previous experiment [29] .
74
The compliance level for each unit can be adjusted to match the vascular distensibilty of a native system 75 for various pathological conditions.
76
A parallel configuration of a solenoid valve and narrow tubing was used to model the coronary perfusion 77 mechanism, as shown in Figure 3 . In a native system, coronary blood flow occurs predominantly during 
80
This allows a small portion of the coronary flow to bypass the valve via the tubing during the systolic phase,
81
but the larger portion of the flow occurs via the solenoid valve during the diastolic phase.
82
Three autoregulation units were attached to the carotid, coronary and renal arteries, as shown in Figure 1 .
83
Each unit takes the form of a pinch valve driven by a stepper motor, as shown in Figure 4 , and applies 84 dilation and constriction to the cerebral, coronary, and renal arteries as occurs in a native system. The flow is 85 adjusted to the autoregulated level when the pressure is within the regulated region, using the appropriate 
Results
91
SCVL Performance
92
A healthy condition and a HF condition were replicated in order to evaluate the efficacy of SCVL Figure 1 , and increasing its compliance. In addition, the 100 vascular distensibility was decreased by reducing the compliance level to simulate a stiffer vascular system 101 and the systemic resistance was increased slightly.
102
The SCVL was tuned so that the pressure and flow rate in healthy and HF conditions matched the smooth waveform is obtained without any signal filtering because the valve closing pressure spikes often 115 present in cardiovascular simulators [35] are dampened by the compliance units. is presented on the basis that the other two units have the same functionality but different autoregulated 125 ranges.
126
Initially, the AoP mean was set at 125 mmHg. In systemic resistance incremental reductions were intro-127 duced into the SCVL system. For each step the AoP mean and CeF mean were recorded after ten seconds to 128 ensure that the transient flow was settled. The step period on the stepper motor was adjusted to ensure the 129 autoregulation response is typically around five seconds as observed in the clinical study [36] , although this 130 varies slightly depending on the magnitude of the pressure change. Table 1 and Table 2 .
147
There is an improvement in CO whether or not the regional autoregulation system is active. At 3000 rpm 148 the CO has increased by 42%. Since there is a large resistance downstream of the pump, the pressure drop the systolic from the diastolic pressure at these circulations, rise by 12% and 30% respectively. renal flow is unaffected at speeds from 0 to 3000 rpm, however at 4000 rpm there is an increase of 22%.
181
When the autoregulation systems are inactive, the renal flow increases proportional to the pressure. 
Discussion
183
The SCVL was used to accurately replicate clinical pressure waveforms and flow rates for healthy and HF 
189
With an integrated RBP, operating over a wide range of rotor speeds in the DA, it was observed that the 190 pressure rise generated downstream of the pump was several times higher than the pressure drop generated 
196
If the comparatively low pressure drop in the aortic arch is replicated in-vivo, it suggests that a beneficial 197 level of support could be applied without significant perfusion drops in cerebral and coronary circulations.
198
With regional autoregulation inactive, a 3000 rpm pump speed resulted in a 42% increase in CO with drops 199 of 17% and 23% in CeF and CoF. Any regional autoregulation activity would reduce these perfusion drops.
200
The pressure rise downstream of the pump improves perfusion to the kidneys. Studies on HF patients
201
showed that the mortality rate is more closely associated with the worsening of renal function than any renal circulation has a high upper limit to its autoregulation system, at 180 mmHg, which was exceeded in 206 our experiment only at the 4000 rpm level of support.
207
With the rotary pump operating in series with the heart, it was observed that the flow pulsatility in all 
211
However, the pulsatility also results in a lower AoP dia which presents a risk to coronary perfusion. A larger 212 perfusion drop was observed in the coronary circulation than in the cerebral circulation during RBP support 213 in the SCVL with regional autoregulation inactive.
214
In this paper the response of the SCVL to a rotary pump in the descending aorta with and without found that with their percutaneous catheter-based pump in the descending aorta of calves, no variation in 219 the coronary perfusion was observed. A drop of 15% in CeF was observed, however in the same study the 220 author emphasized on existing differences between the human and animal cerebral functionality and they
221
predicted that the human cerebral autoregulation system would ensure a sufficient blood supply down to ies [43, 44] showing clearly that the regional autoregulations, particularly cerebral autoregulation is partially 225 impaired in severe HF. However, other studies [45] claim that many patients with moderate to severe HF con-226 dition have a normal regional autoregulation due to the redistribution of the blood flow in the cardiovascular 227 system. In addition, there are studies [44, 46] show that, in some cases after the RBP implantation or heart 228 transplantation, the impaired regional autoregulation has been improved, following CO re-establishment.
229
Whether or not regional autoregulation is impaired due to heart failure, this study has indicated that the 
